Pieris Pharmaceuticals, Inc. logo

Pieris Pharmaceuticals, Inc.

NASDAQ:PIRS

Overview | Financials
Company Name Pieris Pharmaceuticals, Inc.
Symbol PIRS
Currency USD
Price 17.3
Market Cap 22,840,152
Dividend Yield 0%
52-week-range 6.2 - 23.2
Industry Biotechnology
Sector Healthcare
CEO Mr. Stephen S. Yoder J.D.
Website https://www.pieris.com

An error occurred while fetching data.

About Pieris Pharmaceuticals, Inc.

Pieris Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops anticalin-based drugs. The company develops anticalin proteins that are low molecular-weight therapeutic proteins derived from lipocalins, which are naturally occurring low-molecular weight human proteins found in human blood plasma and other bodily fluids. Its lead respiratory Anticalin-based drug candidate includes

Related Stocks

Genenta Science S.p.A. logo

Genenta Science S.p.A.

GNTA

5.45 USD

Graphite Bio, Inc. logo

Graphite Bio, Inc.

GRPH

3.18 USD

ImmunoPrecise Antibodies Ltd. logo

ImmunoPrecise Antibodies Ltd.

IPA

0.418 USD

Apyx Medical Corporation logo

Apyx Medical Corporation

APYX

1.19 USD

ORIC Pharmaceuticals, Inc. logo

ORIC Pharmaceuticals, Inc.

ORIC

9.41 USD

Gritstone bio, Inc. logo

Gritstone bio, Inc.

GRTS

0.032 USD

CorMedix Inc. logo

CorMedix Inc.

CRMD

9.99 USD

Financials

Numbers are in millions USD

Numbers are in millions USD